Doctors say the studies may make healthcare providers more likely to prescribe federally approved medical cannabis for ...

There’s a lot of buzz surrounding the new non-addictive pain pill that is up for FDA approval. It works as well as opioids for treating acute pain, and shows promise in treating chronic neuropathic ...

Researchers at the University of New South Wales Sydney are testing a new way to treat chronic nerve pain by training the ...

After two decades of surgeries, prescriptions, and debilitating symptoms, this mom discovered a treatment that significantly ...

Products with THC reduced pain a little across multiple trials, but those that were mostly CBD didn't outperform placebos.

A systematic review and meta-analysis has found that bisphosphonates—medicines commonly used to treat osteoporosis—may offer ...

Credit: Vertex The active ingredient in Journavx is suzetrigine, a sodium channel blocker. The use of Journavx for moderate to severe pain has not been studied beyond 14 days. The Food and Drug ...

When you have a mild headache or muscle ache, an over-the-counter pain reliever is usually enough to make you feel better. But if your pain is more severe, your doctor might recommend something ...

If you suffer from chronic pain, and modern medicine has done all it can for you, psychological pain management methods based ...

Dr. Adriaan Louw has heard the term "pain revolution" before. The physical therapist and scientist has been researching chronic pain for more than 30 years. Over the decades, he has witnessed the rise ...

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...